ATP Life Science Ventures, L.P. — Q3 2020 13F Holdings

Name: ATP Life Science Ventures, L.P. — 13F Holdings, Q3 2020
Creator: AlphaSMO
License: https://www.sec.gov/forms

CIK: 0001593440

Total reported value

—

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change	4Q Trend
1	STOK	Stoke Therapeutics INC	Stock-Other	75.80%	—	—
2	AKRO	Akero Therapeutics INC	Stock-Other	24.20%	—	+7.66%

Position changes disclosed by ATP Life Science Ventures, L.P. for the quarter ending Q3 2020, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	STOK	Stoke Therapeutics INC	+1.4%	—	Unchanged
2	AKRO	Akero Therapeutics INC	-1.4%	+7.66%	Add